跳至主要内容
临床试验/ITMCTR2000003147
ITMCTR2000003147已完成1 期

The clinical evaluation research of intervention of integrative traditional chinese and western medicine in heart failure with preserved ejection fraction

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 79(—)
性别
All

入选标准

  • 1. Symptoms±Signs of heart failure; LVEF>=45%; LVH/LAE/diastolic dysfunction
  • 2. Aged 18 to 79 years;
  • 3. NYHA classification I to III;
  • 4. Sign the informed consent form.

排除标准

  • 2. Aortic Dissection;
  • 3. Fatal arrhythmia;
  • 4. Acute Heart Failure;
  • 5. Hypertension that cannot be controlled well;
  • 6. Atrial fibrillation/Atrial flutter;
  • 7. Advanced atrioventricular block;
  • 8. Pericardial Diseases;
  • 9. Valvular Disease;
  • 10. Cardiomyopathy;
  • 11. pulmonary embolism;
  • 13. Stroke in the past 3 months/Unfavorable unilateral limb movements due to Stroke;
  • 14. Mental disease;
  • 15. Moderate to severe anemia(HGB<90g/L);
  • 16. Severe hepatic and renal dysfunction(ALT>3 times the normal upper limit, Cr>3mg/dl);
  • 17. People with allergies or known to be allergic to this medicine and ingredients;
  • 18. Disability in the lower limbs or inability to cooperate for various reasons;
  • 19. Women who are preparing for pregnancy, childbearing or breastfeeding in the last 3 months;
  • 20. Participated in other clinical trials in the past 3 months;
  • 21. The survival period not exceeding 3 months;
  • 22. Patients could not complete the study or could not comply with the requirements of the study.

研究者

发起方
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

相似试验

Treatment of heart failure with preserved ejection... | 临床试验